Trial Outcomes & Findings for Topical Nitric Oxide Trial in Chronic Non-Healing Wounds (NCT NCT00823095)
NCT ID: NCT00823095
Last Updated: 2016-02-26
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE2
Target enrollment
7 participants
Primary outcome timeframe
at 28 days post enrollment
Results posted on
2016-02-26
Participant Flow
Participant milestones
| Measure |
Topically Applied Nitric Oxide
Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights.
|
|---|---|
|
Overall Study
STARTED
|
7
|
|
Overall Study
COMPLETED
|
7
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Topical Nitric Oxide Trial in Chronic Non-Healing Wounds
Baseline characteristics by cohort
| Measure |
Group 1
n=7 Participants
Treatment
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
3 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
7 participants
n=5 Participants
|
|
Evidence of a colonized wound on the lower extremity.
>=65 years
|
4 participants
n=5 Participants
|
|
Evidence of a colonized wound on the lower extremity.
18 to 65 years
|
3 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: at 28 days post enrollmentPopulation: Data not available for this study due to dissolution of company contracted to perform study analysis
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 28 days post enrollmentPopulation: Data not available for this study due to dissolution of company contracted to perform analysis.
reduction in bioburden as assessed by number of cfu's per cm2 on culture
Outcome measures
Outcome data not reported
Adverse Events
Group 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place